FMS-like receptor tyrosine kinase-3 inhibitor (Biodol)

N/A

Report date: 2025/03/20 15:04:52
NME

Base Information

Drug NameFMS-like receptor tyrosine kinase-3 inhibitor (Biodol)
Drug Alias NameFLT3 inhibitors (Biodol)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiodol Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesBiodol Therapeutics
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A